Welcure Drugs & Pharmaceuticals on Tuesday said it has completed seven export-sourcing orders of nearly Rs 300 crore in the first quarter of 2025-26.
Export orders were executed as part of fee-based export-sourcing services executed in the ordinary course of business, the company said in a regulatory filing.
"The company has successfully completed seven export-sourcing assignments concluded during Q1 FY 2025-26 worth Rs 299.91 crore. The company acted solely as a procurement agent and earns a fixed 5 per cent commission on the above order," the filing stated.
The company remains focused on expanding its fee-based export portfolio while maintaining its debt-free capital structure, it added.
Last month, it announced bagging two export sourcing assignments worth Rs 85.6 crore. It also secured Rs 517 crore global sourcing mandate with Thailand-based Fortune SagarImpex Company Ltd.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
